Literature DB >> 2169

In vitro release of thymine from DNA by neocarzinostatin.

R Ishida, T Takahashi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 2169     DOI: 10.1016/0006-291x(76)90037-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  7 in total

1.  Endonuclease-resistant apyrimidinic sites formed by neocarzinostatin at cytosine residues in DNA: evidence for a possible role in mutagenesis.

Authors:  L F Povirk; I H Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

2.  Identification of thymidine-5'-aldehyde at DNA strand breaks induced by neocarzinostatin chromophore.

Authors:  L S Kappen; I H Goldberg; J M Liesch
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

3.  Characterization of intracellular DNA strand breaks induced by neocarzinostatin in Escherichia coli cells.

Authors:  E Boye; W Köhnlein; K Skarstad
Journal:  Nucleic Acids Res       Date:  1984-11-12       Impact factor: 16.971

4.  Activation and inactivation of neocarzinostatin-induced cleavage of DNA.

Authors:  L S Kappen; I H Goldberg
Journal:  Nucleic Acids Res       Date:  1978-08       Impact factor: 16.971

5.  Activation of neocarzinostatin chromophore and formation of nascent DNA damage do not require molecular oxygen.

Authors:  L S Kappen; I H Goldberg
Journal:  Nucleic Acids Res       Date:  1985-03-11       Impact factor: 16.971

6.  Distribution and specificity of mutations induced by neocarzinostatin in the lacI gene of Escherichia coli.

Authors:  P L Foster; E Eisenstadt
Journal:  J Bacteriol       Date:  1983-01       Impact factor: 3.490

7.  A pharmacokinetic simulation model for chemotherapy of brain tumor with an antitumor protein antibiotic, neocarzinostatin. Theoretical considerations behind a two-compartment model for continuous infusion via an internal carotid artery.

Authors:  H Maeda; Y Sano; J Takeshita; Z Iwai; H Kosaka; T Marubayashi; Y Matsukado
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.